亚洲欧美不卡高清在线观看,伊人久久大香线蕉午夜av,亚洲综合色区在线观看,中文在线中文a,真正免费的毛片

lenvatinib Mesylate

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:lenvatinib Mesylate
CAS No.:857890-39-2
Standard:ChP, USP, BP, In-house Standards
Price(USD):Negotiable
Company:ZIBO WEIBIN IMP.& EXP.CO.,LTD

Basic Info

  • Grade: Pharmaceutical Grade

    Factory Location: zhejiang

    Main Sales Markets: Asia,Africa

  • Monthly Production Capacity: 1t

    Contract Manufacturing: CRO,CMO

    Packaging Information: 1kg/Aluminum drum

  • Delivery Lead Time: 2-3Week

    Sample Provided: no

    Payment Terms: DP/DA/TT/LC

    Lovatinib is a multi-target tyrosine kinase inhibitor, which may act on a variety of cancers, so Eisai is still studying Lovatinib for other cancers, such as hepatocellular carcinoma, non-small cell lung cancer, melanoma, breast cancer, lymphoma, ovarian cancer, etc. There were 62 clinical studies related to lovatib chemicalbookil. In July 2017, Eisai submitted a marketing application for levatinib as a first-line treatment for advanced hepatocellular carcinoma to the US FDA and the European Medicines Agency. In clinical trials, levatinib was superior to sorafenib, the current standard treatment for advanced hepatocellular carcinoma.

Send your message to this supplier
  • From:
  • To:
    ZIBO WEIBIN IMP.& EXP.CO.,LTD
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service